Tag: NIH

Phase one winners announced in US$9.8 million Neuromod Prize competition

The National Institutes of Health (NIH) Common Fund has named eight winners of the first phase of the Neuromod Prize—a US$9.8 million competition to accelerate...

NIH launches first phase of US$9.8 million competition to accelerate development...

The National Institutes of Health (NIH) has launched the first phase of the Neuromod Prize—a US$9.8 million competition to accelerate the development of neuromodulation therapies....

Rhaeos awarded US$4 million NIH grant to expand sensor technology for...

Rhaeos has been awarded a US$4 million, multi-year grant from the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) programme through the...
synchron stentrode safety

Synchron announces US$10 million NIH grant for US COMMAND trial

The National Institutes of Health (NIH) has collectively awarded Carnegie Mellon University, University of Pittsburgh Medical Center (UPMC), Mount Sinai Health System and Synchron...

NIH study to utilise NeuroPace RNS system for research on the...

NeuroPace has announced that the company’s RNS  system, a closed-loop neuromodulation technology approved to treat adults with medically refractory focal onset epilepsy, will be...

Abbott partners with NIH on BRAIN initiative to advance research for...

Abbott have announced that it has partnered with the National Institutes of Health (NIH) on the BRAIN (Brain Research through Advancing Innovative Neurotechnologies) initiative...